Literature DB >> 22468179

A Four-question Approach to Determining the Impact of Acne Treatment on Quality of Life.

Peter Saitta1, Steven K Grekin.   

Abstract

Facial acne vulgaris can have profound effects on health-related quality of life. In some studies, patients with acne vulgaris reported results similar to those noted with other chronic diseases, such as asthma, arthritis, or diabetes. Clinical objective assessments alone do not adequately capture the impact of acne vulgaris severity from a patient's perspective. Health-related quality-of-life assessment is important in order to fully characterize the overall burden of disease and effectiveness of treatment as the perspectives of the patient are also taken into account. Previous studies of the impact of acne vulgaris treatment on health-related quality of life have been limited in their scope of assessment. Drawbacks of prior studies have included small numbers of patients, health-related quality-of-life parameters that were not adequately evaluated, inclusion of only a limited range of mild-to-moderate acne vulgaris severity, or being unblinded or observational in study design. The Acne Quality of Life is an acne-specific questionnaire developed to assess treatment impact on the health-related quality of life of patients with acne vulgaris. Its psychometric properties and degree of responsiveness are well-established. Improvement in Acne Quality of Life with the fixed combination clindamycin phosphate 1.2%/benzoyl peroxide 2.5% aqueous gel in the largest cohort of acne vulgaris patients where health-related quality of life was studied has been reported recently. Significant improvements in all four domains over 12 weeks were seen with clindamycin phosphate 1.2%/benzoyl peroxide 2.5% aqueous gel compared to patients treated with individual active ingredients or vehicle (p<0.001). Length and time required for completion of the 19-item Acne Quality of Life questionnaire is likely to preclude its use in clinical practice. A condensed, validated Acne Q-4 scale based on the four items most broadly representative of health-related quality of life combined with a high level of correlation to the Acne Quality of Life questionnaire has been suggested as a more realistic approach that may be applied by clinicians when managing patients with acne vulgaris. The authors present data on the effectiveness of clindamycin phosphate 1.2%/benzoyl peroxide 2.5% aqueous gel on health-related quality of life based on this Acne Q-4 scale.

Entities:  

Year:  2012        PMID: 22468179      PMCID: PMC3315878     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  22 in total

1.  The quality of life in acne: a comparison with general medical conditions using generic questionnaires.

Authors:  E Mallon; J N Newton; A Klassen; S L Stewart-Brown; T J Ryan; A Y Finlay
Journal:  Br J Dermatol       Date:  1999-04       Impact factor: 9.302

2.  Health-related quality of life among patients with facial acne -- assessment of a new acne-specific questionnaire.

Authors:  A R Martin; D P Lookingbill; A Botek; J Light; D Thiboutot; C J Girman
Journal:  Clin Exp Dermatol       Date:  2001-07       Impact factor: 3.470

3.  Condensation and validation of a 4-item index of the Acne-QoL.

Authors:  Jerry Tan; Karen Y Fung; Shahedul Khan
Journal:  Qual Life Res       Date:  2006-09-13       Impact factor: 4.147

4.  Responsiveness of the Acne-Specific Quality of Life Questionnaire (Acne-QoL) to treatment for acne vulgaris in placebo-controlled clinical trials.

Authors:  S E Fehnel; L D McLeod; J Brandman; D I Arbit; C J McLaughlin-Miley; J H Coombs; A R Martin; C J Girman
Journal:  Qual Life Res       Date:  2002-12       Impact factor: 4.147

5.  Measuring quality of life in people referred for specialist care of acne: comparing generic and disease-specific measures.

Authors:  A F Klassen; J N Newton; E Mallon
Journal:  J Am Acad Dermatol       Date:  2000-08       Impact factor: 11.527

6.  Evaluating health-related quality of life in patients with facial acne: development of a self-administered questionnaire for clinical trials.

Authors:  C J Girman; S Hartmaier; D Thiboutot; J Johnson; B Barber; C DeMuro-Mercon; J Waldstreicher
Journal:  Qual Life Res       Date:  1996-10       Impact factor: 4.147

7.  Disease-specific quality of life is associated with anxiety and depression in patients with acne.

Authors:  K Yazici; K Baz; A E Yazici; A Köktürk; S Tot; D Demirseren; V Buturak
Journal:  J Eur Acad Dermatol Venereol       Date:  2004-07       Impact factor: 6.166

8.  The use of patient-reported outcome measures in the evaluation of medical products for regulatory approval.

Authors:  L B Burke; D L Kennedy; P H Miskala; E J Papadopoulos; A M Trentacosti
Journal:  Clin Pharmacol Ther       Date:  2008-06-25       Impact factor: 6.875

9.  Practical use of a disability index in the routine management of acne.

Authors:  R J Motley; A Y Finlay
Journal:  Clin Exp Dermatol       Date:  1992-01       Impact factor: 3.470

10.  Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin.

Authors:  D R Rubinow; G L Peck; K M Squillace; G G Gantt
Journal:  J Am Acad Dermatol       Date:  1987-07       Impact factor: 11.527

View more
  2 in total

Review 1.  The role of skin care as an integral component in the management of acne vulgaris: part 1: the importance of cleanser and moisturizer ingredients, design, and product selection.

Authors:  James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2013-12

2.  Assessment of Life Quality Index Among Patients with Acne Vulgaris in a Suburban Population.

Authors:  Neirita Hazarika; Radha K Rajaprabha
Journal:  Indian J Dermatol       Date:  2016 Mar-Apr       Impact factor: 1.494

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.